Sublingual L-GSH Supplementation in Male Subjects With Smoking Habit and/or Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Health Subjects With Cardiovascular Risk Factors
Interventions
DIETARY_SUPPLEMENT

L-GSH

Reduced glutathione is formed by cysteine, glycine and glutamate. It enters into the detoxification processes of endogenous products, such as peroxides which are the final pathway of many reactions caused by cardiovascular risk factors. It also acts on the exogenous compounds, such as pollutants, heavy metals and some drugs.

DIETARY_SUPPLEMENT

Placebo

Placebo will be prepared using the same excipients of the dietary supplement without active substance.

Trial Locations (1)

20162

Oberdan Parodi, MD, Milan

All Listed Sponsors
lead

Niguarda Hospital

OTHER

NCT02125045 - Sublingual L-GSH Supplementation in Male Subjects With Smoking Habit and/or Hypertension | Biotech Hunter | Biotech Hunter